Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-5 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-5 inhibits influenza virus well, and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties (extracted from patent WO2020078401A1, compound 13-1)[1].
Web ID
– HY-143747
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C27H21F2N3O4S2
References
– [1]Huichao LUO, et al. Influenza virus replication inhibitor and uses thereof. Patent WO2020078401A1.
CAS Number
– 2416258-53-0
Molecular Weight
– 553.60
SMILES
– O=C1N2[C@](COCC2)([H])N([C@@H]3C4=CC=C5C=C(C)SC5=C4SCC6=C(F)C(F)=CC=C36)N7C1=C(O)C(C=C7)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
